Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort

被引：10

作者：

Yang, Jun ^{[1
,2
]}

Burrello, Jacopo ^{[3
]}

Goi, Jessica ^{[3
]}

Reincke, Martin ^{[4
]}

Adolf, Christian ^{[4
]}

Asbach, Evelyn ^{[4
]}

Bruedgam, Denise ^{[4
]}

Li, Qifu ^{[5
]}

Song, Yi ^{[5
]}

Hu, Jinbo ^{[5
]}

Yang, Shumin ^{[5
]}

Satoh, Fumitoshi ^{[6
]}

Ono, Yoshikiyo ^{[7
]}

Libianto, Renata ^{[1
]}

Stowasser, Michael ^{[8
]}

Li, Nanfang ^{[9
]}

Zhu, Qing ^{[9
]}

Hong, Namki ^{[10
]}

Nayak, Drishya ^{[11
]}

Puar, Troy H. ^{[12
]}

Wu, Vin-Cent ^{[13
]}

Vaidya, Anand ^{[14
]}

Araujo-Castro, Marta ^{[15
]}

Kocjan, Tomaz ^{[16
]}

O'Toole, Samuel Matthew ^{[17
]}

Hundemer, Gregory L. ^{[18
]}

Ragnarsson, Oskar ^{[19
]}

Lacroix, Andre ^{[20
]}

Larose, Stephanie ^{[20
]}

Nakai, Kazuki ^{[21
]}

Nishikawa, Tetsuo ^{[21
]}

Ladygina, Daria ^{[22
]}

Fturcu, Adina ^{[23
]}

Sholinyan, Julieta ^{[23
]}

Fardella, Carlos E. ^{[24
]}

Uslar, Thomas ^{[24
]}

Quinkler, Marcus ^{[25
]}

Mulatero, Paolo ^{[3
]}

Pintus, Giovanni

Rossi, Gian Paolo

Hahner, Stefanie ^{[27
]}

Amar, Laurence ^{[28
]}

Drake, William M. ^{[29
]}

Varsani, Chetna ^{[29
]}

Brown, Morris J. ^{[30
]}

Wu, Xilin ^{[30
]}

Deinum, Jaap ^{[31
]}

Freel, E. Marie ^{[32
]}

Kline, Gregory ^{[33
]}

Naruse, Mitsuhide ^{[34
]}

机构：

[1] Hudson Inst Med Res, Ctr Endocrinol & Metab, Clayton, Vic 3168, Australia

[2] Monash Univ, Dept Med, Clayton, Vic, Australia

[3] Univ Turin, Dept Med Sci, Internal Med & Hypertens Div, Turin, Italy

[4] LMU Univ Hosp, Dept Nucl Med, Munich, Germany

[5] Chongqing Med Univ, Dept Neurol, Affiliated Hosp 1, Chongqing, Peoples R China

[6] Tohoku Univ, Grad Sch Med, Sendai, Japan

[7] Tohoku Univ Hosp, Dept Diabet Metab & Endocrinol, Sendai, Japan

[8] Univ Queensland, Frazer Inst, Princess Alexandra Hosp, Endocrine Hypertens Res Ctr, Brisbane, Qld, Australia

[9] Peoples Hosp Xinjiang Uygur Autonomous Reg, Ctr Hypertens, Urumqi, Peoples R China

[10] Yonsei Univ, Coll Med, Seoul, South Korea

[11] Princess Alexandra Hosp, Metro South Hlth, Woolloongabba, Qld, Australia

[12] Changi Gen Hosp, SingHlth, Singapore, Singapore

[13] Natl Taiwan Univ Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan

[14] Harvard Med Sch, Brigham & Womens Hosp, Ctr Adrenal Disorders, Boston, MA USA

[15] Ramon & Cajal Hosp, Dept Cardiol, Madrid, Spain

[16] Univ Med Ctr Ljubljana, Ljubljana, Slovenia

[17] Royal Hallamshire Hosp, Dept Endocrinol, Sheffield, England

[18] Univ Ottawa, Dept Med, Div Nephrol, Ottawa, ON, Canada

[19] Univ Gothenburg, Wallenberg Ctr Mol & Translat Med, Gothenburg, Sweden

[20] Ctr Hosp Univ Montreal, Ctr hosp, Montreal, PQ, Canada

[21] Yokohama Rosai Hosp, Endocrinol & Diabet Ctr, Yokohama, Japan

[22] Fed State Autonomous Educ Inst Higher Educ IM Sec, Moscow, Russia

[23] Univ Michigan, Div Metab Endocrinol & Diabet, Ann Arbor, MI USA

[24] Univ Catolica Chile CETREN UC, Ctr Estudios Gest & Polit QSV, Santiago, Chile

[25] Endocrinol Charlottenburg, Berlin, Germany

[26] Univ Padua, Dept Med, Specialized Ctr Blood Pressure Disorders Reg Vene, Padua, Italy

[27] Univ Hosp Wurzburg, Dept Internal Med, Div Endocrinol & Diabet, Wurzburg, Germany

[28] Univ Paris Cite, AP HP, Adrenal Referral Ctr, Paris, France

[29] St Barthlomews Hosp, London, England

[30] Univ London, Queen Mary Hosp, London, England

[31] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands

[32] Queen Elizabeth Univ Hosp, Glasgow, Scotland

[33] Univ Calgary, Calgary, AB, Canada

[34] NHO Kyoto Med Ctr, Inst Clin Endocrinol & Metab, Kyoto, Japan

[35] Natl Inst Cardiol, Dept Epidemiol Cardiovasc Dis Prevent & Hlth Prom, Warsaw, Poland

[36] Mayo Clin, Dept Internal Med, Rochester, MN USA

[37] Monash Hlth, Dept Endocrinol, Clayton, Vic, Australia

来源：

LANCET DIABETES & ENDOCRINOLOGY | 2025年 / 13卷 / 02期

关键词：

ADRENALECTOMY; HYPERTENSION; DIAGNOSIS;

D O I：

10.1016/S2213-8587(24)00308-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background Primary aldosteronism can be treated medically but there is no standardised method to evaluate treatment outcomes. We aimed to develop criteria for assessing the outcomes of targeted medical treatment of primary aldosteronism, analyse outcomes across an international cohort, and identify factors associated with a complete treatment response. Methods An international panel of 31 primary aldosteronism experts used the Delphi method to reach consensus on the definition of complete, partial, or absent biochemical and clinical outcomes of medical treatment of primary aldosteronism. Clinical data at baseline and 6-12 months post-treatment were collected from patients with primary aldosteronism who started targeted medical treatment between 2016 and 2021 at 28 participating centres. Findings Consensus was reached for defining complete, partial, or absent biochemical or clinical response. Of 1258 patients (with a mean age of 52 years [SD 11<middle dot>5] and of whom 610 [48<middle dot>5%] were female and 648 [51<middle dot>5%] were male), 1057 (84<middle dot>0%) had biochemical outcome data (559 [52<middle dot>9%] had a complete biochemical response). The median daily dose of spironolactone was significantly higher for those with a complete biochemical response than for those without (40 mg [IQR 25-50] vs 25 mg [20-50]; p=0<middle dot>011). Of the 1248 patients with clinical outcome data, 228 [18<middle dot>3%] had a complete clinical response whereas 227 (18<middle dot>2%) had an absent response. Patients with a complete clinical response were more likely than those with partial or absent clinical response to be women (OR 2<middle dot>099, 95% CI 1<middle dot>485-2<middle dot>968; p<0<middle dot>001), require lower doses of antihypertensive drugs at baseline (0<middle dot>687, 0<middle dot>603-0<middle dot>782; p<0<middle dot>001), and were less likely to have microalbuminuria or left ventricular hypertrophy (0<middle dot>584, 0<middle dot>391-0<middle dot>873; p=0<middle dot>009). Interpretation The Primary Aldosteronism Medical Treatment Outcome (PAMO) criteria represent an internationally developed outcome standard that can guide clinical practice and research into primary aldosteronism. Efforts to optimise treatment intensity and minimise factors associated with an absent treatment response are needed to improve patient outcomes. Copyright (c) 2025 Elsevier Ltd. All rights reserved, including those for text and data mining, AI training, and similar technologies.

引用

页码：119 / 133

页数：15

共 26 条

[21] Real-World Effectiveness of Mineralocorticoid Receptor Antagonists in Primary Aldosteronism [J].

Tezuka, Yuta ;

Turcu, Adina F. .

FRONTIERS IN ENDOCRINOLOGY, 2021, 12

[22] Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials [J].

Wald, David S. ;

Law, Malcolm ;

Morris, Joan K. ;

Bestwick, Jonathan P. ;

Wald, Nicholas J. .

AMERICAN JOURNAL OF MEDICINE, 2009, 122 (03) :290-300

[23] Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort [J].

Williams, Tracy A. ;

Lenders, Jacques W. M. ;

Mulatero, Paolo ;

Burrello, Jacopo ;

Rottenkolber, Marietta ;

Adolf, Christian ;

Satoh, Fumitoshi ;

Amar, Laurence ;

Quinkler, Marcus ;

Deinum, Jaap ;

Beuschlein, Felix ;

Kitamoto, Kanako K. ;

Uyen Pham ;

Morimoto, Ryo ;

Umakoshi, Hironobu ;

Prejbisz, Aleksander ;

Kocjan, Tomaz ;

Naruse, Mitsuhide ;

Stowasser, Michael ;

Nishikawa, Tetsuo ;

Young, William F., Jr. ;

Gomez-Sanchez, Celso E. ;

Funder, John W. ;

Reincke, Martin .

LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (09) :689-699

[24] International Histopathology Consensus for Unilateral Primary Aldosteronism [J].

Williams, Tracy Ann ;

Gomez-Sanchez, Celso E. ;

Rainey, William E. ;

Giordano, Thomas J. ;

Lam, Alfred K. ;

Marker, Alison ;

Mete, Ozgur ;

Yamazaki, Yuto ;

Nogueira Zerbini, Maria Claudia ;

Beuschlein, Felix ;

Satoh, Fumitoshi ;

Burrello, Jacopo ;

Schneider, Holger ;

Lenders, Jacques W. M. ;

Mulatero, Paolo ;

Castellano, Isabella ;

Knosel, Thomas ;

Papotti, Mauro ;

Saeger, Wolfgang ;

Sasano, Hironobu ;

Reincke, Martin .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (01) :42-54

[25] Mineralocorticoid receptor signalling in primary aldosteronism [J].

Yang, Jun ;

Young, Morag J. ;

Cole, Timothy J. ;

Fuller, Peter J. .

JOURNAL OF ENDOCRINOLOGY, 2023, 259 (01)

[26] Nomogram-Based Preoperative Score for Predicting Clinical Outcome in Unilateral Primary Aldosteronism [J].

Yang, Yi ;

Williams, Tracy Ann ;

Song, Ying ;

Yang, Shumin ;

He, Wenwen ;

Wang, Kanran ;

Cheng, Qingfeng ;

Ma, Linqiang ;

Luo, Ting ;

Yang, Jun ;

Reincke, Martin ;

Burrello, Jacopo ;

Li, Qifu ;

Mulatero, Paolo ;

Hu, Jinbo .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (12)

← 1 2 3 →